JUST IN: 🇺🇸 Senate Republicans have officially introduced CRYPTO TAX BILL. 💥SOMETHING BIG IS COMING!💥

$XRP BREAKOUT WITHIN 48 HOURS!

🚨THIS IS HUUUUGE! 🇺🇸 The SEC has granted a five-year license to trade tokenized stocks. AMERICA IS ABOUT TO BECOME THE CRYPTO CAPITAL OF THE WORLD! 🔥

Bitcoin just hit $85,000 and ETH is ripping hard, liquidating $60 million shorts in just 15 minutes. This happened after GDP came in much higher than expected at 2.2% and PCE inflation dropped to a 6-month low.

Top Watch 🚨 $OPTH PSYCHEDELIC MEDICINE a GAME CHANGING alternative to DEPRESSION + PTSD treatment. Optimi Health is already tapping into commercialization while most companies remain in the development stage. They have a first mover advantage on competition! Optimi Health is already manufacturing and supplying regulated psychedelic medicines. ➡️ Commercial psilocybin already reaching Australia ➡️ Exposure to both MDMA + psilocybin ➡️ Health Canada-licensed manufacturing infrastructure ➡️ Clinical programs targeting depression + PTSD 🌎 Growing international footprint across multiple markets As regulated psychedelic medicine expands, $OPTH already has: ⚡️manufacturing ⚡️products ⚡️commercial infrastructure in place to capitalize. Definitely a psychedelic name to watch! Communicated-Disclaimer- stockresearchtoday.com/opth/

💲💲 Top Gainers 💲💲 $NIVF +137.5% $CNTB +91.8% NEWS $LGHL +63.4% NEWS $VBIO +38.1% NEWS $NCI +38.1% $FFR +25.7% NEWS $TGE +24.1% NEWS $RETO +22.2% $WETO +20.9% $BIYA +19.5% $AEON +18.6% NEWS $FRGT +16.5% $CAPR +15.8% $ONMD +14.2% NEWS $FNGR +14.0% Premarket theme: low priced momentum and fresh PR catalysts are driving the action, with heavy volume hitting several small-cap names.

BREAKING: Inventories in the US Strategic Petroleum Reserve fell by ~800,000 barrels last week, to 283.8 million barrels, the lowest level since 1982. This marks the 27th consecutive weekly decline, putting inventories down more than -132 million barrels from their high. Meanwhile, the Trump Administration is now offering up to 40 million barrels of crude oil from the SPR, which would could drive total inventories below 250 million barrels. America's oil reserves are running near their lowest levels in history.

💡 Idea 💡 $OPTH PSYCHEDELIC MEDICINE IS GAINING TRACTION, AND OPTIMI IS ALREADY IN THE GAME with an edge on competition. 💪 Optimi Health is BEYOND development, and already producing GMP grade psilocybin and MDMA for regulated commercial and clinical use. ⏳️ The next stage could bring some major milestones, like: ▪️200 patient Phase 2 psilocybin study targeting Major Depressive Disorder ▪️100 patient Phase 3 MDMA study planned for PTSD in veterans and frontline workers ▪️New 5mg psilocybin capsule batch quality released ▪️Commercial supply reaching regulated markets including Canada and Australia 👀 Potential Catalysts: ▪️Patient enrollment and clinical updates ▪️Progress toward the Phase 3 MDMA program ▪️New supply agreements ▪️Further international expansion With depression and PTSD representing enormous unmet treatment needs, OPTH is one psychedelic name worth keeping on the radar. Depression alone impacts millions yearly. Communicated-Disclaimer- stockresearchtoday.com/opth/

🚨 $OPTH PSYCHEDELIC MEDICINE name that is GAME CHANGING in depression and PTSD treatment. 📈 CHART: Tight triangle around $4.88 with rising support. MACD turning positive and RSI near 51. Volume breakout is key, and could send this low float back to the highs. TOP 5 BULLISH POINTS ✓ Commercial psychedelic sales already underway ✓ Psilocybin targeting major depressive disorder ✓ Already supplying treatment-resistant depression market ✓ Phase 3 MDMA/PTSD program planned ✓ Health Canada-licensed GMP manufacturing Depression remains a major mental health challenge with a need for new treatment options. $OPTH is a name to watch as psychedelic medicine moves toward broader clinical and commercial use. Communicated-Disclaimer- stockresearchtoday.com/opth/

🚨📈 Today's Leaderboard 📈🚨 $KOD +106.62% | $66.57 Phase 3 DAYBREAK results sent shares sharply higher after Zenkuda and tabirafusp-ted met all primary endpoints in wet AMD. $SOAR +69.97% | $0.30 Major move after subsidiary Alignment Engine landed $1.2B in four-year take-or-pay orders tied to dedicated AMD GPU infrastructure. Important context: SOAR owns a 5% stake in the subsidiary. $GYGY +71.71% | $1.27 Heavy volume following the commercial rollout of GameGolf KZN, its AI-powered golf shot-tracking and analytics platform. $ARAY +39.75% | $0.30 Moving after announcing a collaboration with Samsung NeuroLogica focused on bringing advanced volumetric imaging capabilities to the CyberKnife System. $CLRO +55.36% | $5.37 Strong speculative momentum as traders position around the expected October 2026 reverse merger with neurotechnology company Cortigent. $LABT +32.34% | $2.22 Positive preclinical results for Nu-3 showed encouraging activity against resistant pathogens associated with infected diabetic foot ulcers. $MEDS +26.05% | $3.93 Higher following the launch of its “Health Lives Here” mobile platform offering telehealth and AI-supported coaching for GLP-1 users through its NFL Alumni Health partnership. $WBUY +22.53% | $1.02 First-half 2026 results showed revenue nearly doubled as the company's shift toward travel services gained traction. $MIMI +30.96% | $1.02 AI and robotics momentum continues following recent partnership announcements. No fresh company-specific catalyst identified this morning. $AMPU +21.33% | $2.56 The 2x AMPX-linked ETF is moving alongside Amprius Technologies after AMPX secured a $75M U.S. government grant supporting domestic drone-battery production. $HBR +27.81% | $16.60 Strong premarket move, but no clear new company-specific catalyst identified.

🚨 $OPTH COMMERCIAL PSYCHEDELIC MEDICINE IS HERE, AND OPTH IS ALREADY IN THE GAME. They're emerging as a KEY PLAYER in the space. Optimi Health is building something that separates it from many early stage psychedelic companies: commercial operations alongside an active clinical pipeline. The company is ALREADY MANUFACTURING AND SUPPLYING psychedelic medicines, with commercial psilocybin shipments reaching patients in Australia for treatment resistant depression. 🔑 Key points that stand out: ➡️ COMMERCIAL-STAGE OPERATIONS Psilocybin products are already being supplied into Australia's regulated market. ➡️ MDMA + PSILOCYBIN PLATFORM Exposure to two of the most closely watched compounds in psychedelic-assisted medicine. ➡️ HEALTH CANADA-LICENSED INFRASTRUCTURE Manufacturing capabilities include producing, packaging, testing and exporting controlled pharmaceutical products. ➡️ ACTIVE CLINICAL DEVELOPMENT Programs include work involving major depressive disorder and MDMA-assisted therapy for PTSD. 🌎 INTERNATIONAL REACH Products have reached Australia, Canada and the UK, creating multiple potential avenues for expansion. Optimi Health has an EDGE on competition as they are already building the manufacturing, clinical and commercial footprint to participate as regulated access expands. A strong contender in the psychedelic medicine space, and name to keep on your radar! Communicated-Disclaimer- stockresearchtoday.com/opth/

📈📈 Trading Tips 📈📈 Moving averages are one of the simplest ways to clean up a chart and see what price is actually doing. 5/8/13 MA → Short-term momentum + early trend shifts 50 MA → Mid-term trend changes 100 MA → Pullback/support areas in established trends 200 MA → Major long-term trend level 50 MA crosses BELOW 200 MA → Death Cross / bearish shift 50 MA crosses ABOVE 200 MA → Golden Cross / bullish shift The crossover alone isn’t the trade. Watch how price reacts at the level, then look for confirmation with price action and volume. Find the setup. Wait for confirmation. Manage the risk. #Trading #DayTrading #StockMarket #TechnicalAnalysis #TradingTips

💲💲 Top Crypto Gainers 💲💲 Follow for more updates. $QI $PHA $NYM $BTW $ARK $BONER $BP $TREAD $GSTOCK #Crypto #CryptoTrading #CryptoGainers #Altcoins #AltcoinSeason #CryptoMarket #CryptoNews #CryptoTrader #TopGainers #CryptoWatchlist #TradeGOAT #Web3

WOW Someone Just Added $20 MILLION+ Worth of $META Calls This is serious size for Meta

BREAKING: Trump is consider building Chinese EVs in US, per NBC

$ZSQR So much to love about this setup, from a powerful pipeline supported by a strong management team as they tackle one of the biggest obstacles, POWER. Operating cash ✅️ No dilution ✅️ 80% of O/S shares are locked up 🔒 Nice untrend channel on the chart 📈 A strong watch for me this year! Related names - $APLD $IREN $WULF $CIFR $HUT $RIOT $CRWV $NBIS $DLR $EQIX #AI Communicated-Disclaimer- tinyurl.com/sh2rck4a

🚨 Top Watch 🚨 $ZSQR: POWERING THE $5.2 TRILLION AI INFRASTRUCTURE BOOM. TOP BULLISH POINTS ✓ 8 MW LIVE POWER TODAY .. acquired Union County AI infrastructure campus ✓ TARGETING UP TO 150 MW .. development pathway at Union County ✓ NO CASH + NO DEBT FINANCING used for the Paradox acquisition $15.5M CASH + VIRTUALLY NO CORPORATE DEBT SHARE STRUCTURE COULD ADD FUEL 80% of outstanding shares restricted through Oct. 2027, potentially limiting supply and amplifying momentum as demand builds. Limited supply. AI infrastructure growth ahead. CAPITAL DISCIPLINE = SHAREHOLDER FOCUSED $300M S-3 deregistered. $300M ATM cancelled. $50M forward terminated. ZERO shares sold through these programs. Management has made it clear: remove unnecessary dilution overhang and pursue future capital around meaningful project milestones. This is HUGE for shareholder value. Related names - $APLD $IREN $WULF $CIFR $HUT $RIOT $CRWV $NBIS $DLR $EQIX Communicated-Disclaimer- tinyurl.com/sh2rck4a